Követés
Anthony S. Wierzbicki
Anthony S. Wierzbicki
Consultant (Honorary Professor) in Metabolic Medicine, Guy's & St Thomas' Hospitals London UK
E-mail megerősítve itt: kcl.ac.uk
Cím
Hivatkozott rá
Hivatkozott rá
Év
The agenda for familial hypercholesterolemia: a scientific statement from the American Heart Association
SS Gidding, M Ann Champagne, SD de Ferranti, J Defesche, MK Ito, ...
Circulation 132 (22), 2167-2192, 2015
6352015
Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation
GF Watts, S Gidding, AS Wierzbicki, PP Toth, R Alonso, WV Brown, ...
International journal of cardiology 171 (3), 309-325, 2014
5762014
Familial hypercholesterolaemia
JC Defesche, SS Gidding, M Harada-Shiba, RA Hegele, RD Santos, ...
Nature reviews Disease primers 3 (1), 1-20, 2017
5302017
Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial.
J Armitage, L Bowman, K Wallendszus, R Bulbulia, K Rahimi, R Haynes, ...
Lancet (London, England) 376 (9753), 2010
5252010
Homocysteine and cardiovascular disease: a review of the evidence
AS Wierzbicki
Diabetes and Vascular Disease Research 4 (2), 143-149, 2007
4042007
The lipid and non-lipid effects of statins
AS Wierzbicki, R Poston, A Ferro
Pharmacology & therapeutics 99 (1), 95-112, 2003
3512003
Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: summary of updated NICE guidance
S Rabar, M Harker, N O’Flynn, AS Wierzbicki
Bmj 349, 2014
3342014
“European panel on low density lipoprotein (LDL) subclasses”: a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses
D P Mikhailidis, M Elisaf, M Rizzo, K Berneis, B Griffin, A Zambon, ...
Current vascular pharmacology 9 (5), 533-571, 2011
3222011
Molecular genetics and phenotypic characteristics of MODY caused by hepatocyte nuclear factor 4α mutations in a large European collection
ER Pearson, S Pruhova, CJ Tack, A Johansen, HAJ Castleden, PJ Lumb, ...
Diabetologia 48, 878-885, 2005
2992005
Familial hypercholesterolaemia: summary of NICE guidance
AS Wierzbicki, SE Humphries, R Minhas
Bmj 337, 2008
2852008
Multiple actions of high-density lipoprotein
M Florentin, EN Liberopoulos, AS Wierzbicki, DP Mikhailidis
Current opinion in cardiology 23 (4), 370-378, 2008
2822008
Relation of erectile dysfunction to angiographic coronary artery disease
H Solomon, JW Man, AS Wierzbicki, G Jackson
American Journal of Cardiology 91 (2), 230-231, 2003
2682003
Psychological impact of genetic testing for familial hypercholesterolemia within a previously aware population: a randomized controlled trial
T Marteau, V Senior, SE Humphries, M Bobrow, T Cranston, MA Crook, ...
American journal of medical genetics Part A 128 (3), 285-293, 2004
2232004
Refsum's disease: a peroxisomal disorder affecting phytanic acid α‐oxidation
AS Wierzbicki, MD Lloyd, CJ Schofield, MD Feher, FB Gibberd
Journal of neurochemistry 80 (5), 727-735, 2002
2122002
Statin-fibrate combination therapy for hyperlipidaemia: a review
AS Wierzbicki, DP Mikhailidis, R Wray, M Schachter, R Cramb, ...
Current medical research and opinion 19 (3), 155-168, 2003
2082003
American heart association atherosclerosis, hypertension, and obesity in young committee of council on cardiovascular disease in young, council on cardiovascular and stroke …
SS Gidding, MA Champagne, SD de Ferranti, J Defesche, MK Ito, ...
Circulation 132 (22), 2167-92, 2015
1932015
Identification of PEX7 as the second gene involved in Refsum disease
DM Van Den Brink, P Brites, J Haasjes, AS Wierzbicki, J Mitchell, ...
The American Journal of Human Genetics 72 (2), 471-477, 2003
1922003
α‐Methylacyl‐CoA racemase–an ‘obscure’metabolic enzyme takes centre stage
MD Lloyd, DJ Darley, AS Wierzbicki, MD Threadgill
The FEBS Journal 275 (6), 1089-1102, 2008
1502008
Polymorphisms in the P450 c17 (17-hydroxylase/17, 20-Lyase) and P450 c19 (aromatase) genes: association with serum sex steroid concentrations and bone mineral density in …
J Somner, S McLellan, J Cheung, YT Mak, ML Frost, KM Knapp, ...
The Journal of Clinical Endocrinology & Metabolism 89 (1), 344-351, 2004
1492004
Integrated guidance on the care of familial hypercholesterolemia from the International FH Foundation
GF Watts, S Gidding, AS Wierzbicki, PP Toth, R Alonso, WV Brown, ...
Journal of Clinical Lipidology 8 (2), 148-172, 2014
1452014
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20